Albert S. Cornelius
Pediatric Hematology Oncology
3950 Hollywood Road
Suite 240
Saint Joseph, MI 49085
Suite 240
Saint Joseph, MI 49085
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Neratinib Alone or in Combination with Immune Checkpoint Inhibitors with or without Mammalian Target of Rapamycin Inhibitors in Patients with Fibrolamellar Carcinoma.
Journal: Liver cancer
Published: February 20, 2024
Rare cases of medulloblastoma with hypermutation.
Journal: Cancer reports (Hoboken, N.J.)
Published: May 26, 2021
Genomic and Transcriptomic Analysis of Relapsed and Refractory Childhood Solid Tumors Reveals a Diverse Molecular Landscape and Mechanisms of Immune Evasion.
Journal: Cancer research
Published: April 02, 2021
Excellent outcome of young children with nodular desmoplastic medulloblastoma treated on "Head Start" III: a multi-institutional, prospective clinical trial.
Journal: Neuro-oncology
Published: April 19, 2020
Pre-irradiation intensive induction and marrow-ablative consolidation chemotherapy in young children with newly diagnosed high-grade brainstem gliomas: report of the "head-start" I and II clinical trials.
Journal: Journal of neuro-oncology
Published: June 14, 2018
Molecular Guided Therapy Provides Sustained Clinical Response in Refractory Choroid Plexus Carcinoma.
Journal: Frontiers in pharmacology
Published: June 16, 2017
Outcome of young children with high-grade glioma treated with irradiation-avoiding intensive chemotherapy regimens: Final report of the Head Start II and III trials.
Journal: Pediatric blood & cancer
Published: March 30, 2015
Intensive induction chemotherapy followed by myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for young children newly-diagnosed with central nervous system atypical teratoid/rhabdoid tumors: the Head Start III experience.
Journal: Pediatric blood & cancer
Published: November 02, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026